PMV PHARMACEUTICALS, INC. Dividends, Preferred Stock
PMV PHARMACEUTICALS, INC. (PMVP) reported Dividends, Preferred Stock of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-01.
Discontinued › Shareholders' Equity
us-gaap:DividendsPreferredStock · last filed 2022-03-01
- PMV PHARMACEUTICALS, INC. dividends, preferred stock for fiscal 2019 was $0.00.
| Period end | Dividends, Preferred Stock 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |